drugset / Trial / NCT03991000
Iron in Patients With Cardiovascular Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
It is now recognized that iron deficiency in cardiovascular disease contributes to impaired clinical outcome.
Timeline
- Start
- 2019-02-28
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferric carboxymaltose | Other / unclassified | 500 mg | Intravenous |